Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5718255 | 1.00 | CA2 (0.59) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| SCHEMBL3777741 | 1.00 | CA2 (0.59) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| SCHEMBL29229502 | 1.00 | CA2 (0.59) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| SCHEMBL2986282 | 1.00 | CA2 (0.59) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| Water SCHEMBL1654584 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| Water SCHEMBL21835627 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| Water SCHEMBL1322817 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| Water SCHEMBL21457923 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| Water SCHEMBL21457922 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 | |
| SCHEMBL2854360 | 0.98 | CA2 (0.57) | CA2ALDH1A1SMN1; SMN2CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9631 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722214-A1 | METHOD OF PREPARING FINERENONE, INTERMEDIATE COMPOUND OF FINERENONE, AND METHOD OF PREPARING THE INTERMEDIATE COMPOUND | JW Pharmaceutical Corporation (KR) | 2026-04-08 | — | — | EP | claimed |
| US-12441745-B2 | Processes and compounds | RADIUS PHARMACEUTICALS, INC. (US) | 2025-10-14 | — | — | US | claimed |
| US-20250276974-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.P.A. (IT) | 2025-09-04 | — | — | US | claimed |
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2025-08-28 | — | — | US | claimed |
| WO-2025133917-A1 | PROCESS FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5- ETHOXY-1, 4-DIHYDRO-2,8-DIMETHYL-1,6-NAPTHYRIDINE-3-CARBOXAMIDE | INDUSTRIALE CHIMICA S.R.L. (IT) | 2025-06-26 | — | — | WO | claimed |
| CN-119954778-A | Synthesis method of lenacipam sodium and series of intermediate compounds thereof | 杭州科巢生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| US-20250115601-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-04-10 | — | — | US | claimed |
| EP-4526302-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | Alivus Life Sciences Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| US-12247030-B2 | Process for preparing compositions comprising an enantiomeric excess of a substituted pyrrolo[2,3-d]pyrimidine | INCYTE HOLDINGS CORPORATION (US) | 2025-03-11 | — | — | US | claimed |
| CN-119569588-A | Preparation method and intermediate of ilast hydrochloride | 杭州诺澳生物医药科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-4931557-A | Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1990-06-05 | — | — | US | claimed |
| EP-0365213-A2 | Method of resolving cis 3-amino-4-[2-(2-furyl)vinyl]-1-methoxy-carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0251904-B1 | PROCESS FOR THE PREPARATION OF ACIDIC LEVOMEPROMAZINE MALEATE | RHONE-POULENC SANTE (FR) | 1990-01-10 | — | — | EP | claimed |
| US-4798895-A | Process for preparing levomepromazine hydrogen maleate | RHONE-POULENC SANTE (FR) | 1989-01-17 | — | — | US | claimed |
| US-4471121-A | Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1984-09-11 | — | — | US | claimed |
| EP-0112604-A1 | Novel resolved keto compounds and process | ELI LILLY AND COMPANY (US) | 1984-07-04 | — | — | EP | claimed |
| US-4458084-A | Cyclopentene derivatives | THE UPJOHN COMPANY (US) | 1984-07-03 | — | — | US | claimed |
| US-4353918-A | ANTIINFLAMMATORY, ANTIRHEUMATIC | CIBA-GEIGY CORPORATION (US) | 1982-10-12 | — | — | US | claimed |
| US-4329469-A | SUSPENSION, SALT FORMATION | MERCK & CO., INC. (US) | 1982-05-11 | — | — | US | claimed |
| US-4072698-A | OPTICALLY ACTIVE ACIDS WITH KETONE OR ALDEHYDE CATALYST | THE UPJOHN COMPANY (US) | 1978-02-07 | — | — | US | claimed |